Health and health care; personal characteristics
| Characteristics | Margins | Periods | Acute diseases Corona (%) |
|---|---|---|---|
| Total persons | Value | 2025 | . |
| Total persons | Lower bound 95% confidence interval | 2025 | . |
| Total persons | Upper bound 95% confidence interval | 2025 | . |
| Sex: Male | Value | 2025 | . |
| Sex: Male | Lower bound 95% confidence interval | 2025 | . |
| Sex: Male | Upper bound 95% confidence interval | 2025 | . |
| Sex: Female | Value | 2025 | . |
| Sex: Female | Lower bound 95% confidence interval | 2025 | . |
| Sex: Female | Upper bound 95% confidence interval | 2025 | . |
| Age: 0 to 3 years | Value | 2025 | . |
| Age: 0 to 3 years | Lower bound 95% confidence interval | 2025 | . |
| Age: 0 to 3 years | Upper bound 95% confidence interval | 2025 | . |
| Age: 4 to 11 years | Value | 2025 | . |
| Age: 4 to 11 years | Lower bound 95% confidence interval | 2025 | . |
| Age: 4 to 11 years | Upper bound 95% confidence interval | 2025 | . |
| Age: 12 to 15 years | Value | 2025 | . |
| Age: 12 to 15 years | Lower bound 95% confidence interval | 2025 | . |
| Age: 12 to 15 years | Upper bound 95% confidence interval | 2025 | . |
| Age: 16 to 19 years | Value | 2025 | . |
| Age: 16 to 19 years | Lower bound 95% confidence interval | 2025 | . |
| Age: 16 to 19 years | Upper bound 95% confidence interval | 2025 | . |
| Age: 20 to 29 years | Value | 2025 | . |
| Age: 20 to 29 years | Lower bound 95% confidence interval | 2025 | . |
| Age: 20 to 29 years | Upper bound 95% confidence interval | 2025 | . |
| Age: 30 to 39 years | Value | 2025 | . |
| Age: 30 to 39 years | Lower bound 95% confidence interval | 2025 | . |
| Age: 30 to 39 years | Upper bound 95% confidence interval | 2025 | . |
| Age: 40 to 49 years | Value | 2025 | . |
| Age: 40 to 49 years | Lower bound 95% confidence interval | 2025 | . |
| Age: 40 to 49 years | Upper bound 95% confidence interval | 2025 | . |
| Age: 50 to 54 years | Value | 2025 | . |
| Age: 50 to 54 years | Lower bound 95% confidence interval | 2025 | . |
| Age: 50 to 54 years | Upper bound 95% confidence interval | 2025 | . |
| Age: 55 to 64 years | Value | 2025 | . |
| Age: 55 to 64 years | Lower bound 95% confidence interval | 2025 | . |
| Age: 55 to 64 years | Upper bound 95% confidence interval | 2025 | . |
| Age: 65 to 74 years | Value | 2025 | . |
| Age: 65 to 74 years | Lower bound 95% confidence interval | 2025 | . |
| Age: 65 to 74 years | Upper bound 95% confidence interval | 2025 | . |
| Age: 75 years or older | Value | 2025 | . |
| Age: 75 years or older | Lower bound 95% confidence interval | 2025 | . |
| Age: 75 years or older | Upper bound 95% confidence interval | 2025 | . |
| Age: 0 to 11 years | Value | 2025 | . |
| Age: 0 to 11 years | Lower bound 95% confidence interval | 2025 | . |
| Age: 0 to 11 years | Upper bound 95% confidence interval | 2025 | . |
| Age: 12 to 17 years | Value | 2025 | . |
| Age: 12 to 17 years | Lower bound 95% confidence interval | 2025 | . |
| Age: 12 to 17 years | Upper bound 95% confidence interval | 2025 | . |
| Age: 18 years or older | Value | 2025 | . |
| Age: 18 years or older | Lower bound 95% confidence interval | 2025 | . |
| Age: 18 years or older | Upper bound 95% confidence interval | 2025 | . |
| The Netherlands | Value | 2025 | . |
| The Netherlands | Lower bound 95% confidence interval | 2025 | . |
| The Netherlands | Upper bound 95% confidence interval | 2025 | . |
| Europe (excluding the Netherlands) | Value | 2025 | . |
| Europe (excluding the Netherlands) | Lower bound 95% confidence interval | 2025 | . |
| Europe (excluding the Netherlands) | Upper bound 95% confidence interval | 2025 | . |
| Outside Europe | Value | 2025 | . |
| Outside Europe | Lower bound 95% confidence interval | 2025 | . |
| Outside Europe | Upper bound 95% confidence interval | 2025 | . |
| Origin: born in the Netherlands | Value | 2025 | . |
| Origin: born in the Netherlands | Lower bound 95% confidence interval | 2025 | . |
| Origin: born in the Netherlands | Upper bound 95% confidence interval | 2025 | . |
| Origin: born in NL, parents in NL | Value | 2025 | . |
| Origin: born in NL, parents in NL | Lower bound 95% confidence interval | 2025 | . |
| Origin: born in NL, parents in NL | Upper bound 95% confidence interval | 2025 | . |
| Origin: born in NL, parent(s) abroad | Value | 2025 | . |
| Origin: born in NL, parent(s) abroad | Lower bound 95% confidence interval | 2025 | . |
| Origin: born in NL, parent(s) abroad | Upper bound 95% confidence interval | 2025 | . |
| Origin: born in NL, parent(s) in Europe | Value | 2025 | . |
| Origin: born in NL, parent(s) in Europe | Lower bound 95% confidence interval | 2025 | . |
| Origin: born in NL, parent(s) in Europe | Upper bound 95% confidence interval | 2025 | . |
| Origin: born NL, parent(s) out. Europe | Value | 2025 | . |
| Origin: born NL, parent(s) out. Europe | Lower bound 95% confidence interval | 2025 | . |
| Origin: born NL, parent(s) out. Europe | Upper bound 95% confidence interval | 2025 | . |
| Origin: born abroad | Value | 2025 | . |
| Origin: born abroad | Lower bound 95% confidence interval | 2025 | . |
| Origin: born abroad | Upper bound 95% confidence interval | 2025 | . |
| Origin: born in Europe (excl. NL) | Value | 2025 | . |
| Origin: born in Europe (excl. NL) | Lower bound 95% confidence interval | 2025 | . |
| Origin: born in Europe (excl. NL) | Upper bound 95% confidence interval | 2025 | . |
| Origin: born outside Europe | Value | 2025 | . |
| Origin: born outside Europe | Lower bound 95% confidence interval | 2025 | . |
| Origin: born outside Europe | Upper bound 95% confidence interval | 2025 | . |
| Position: single; < 40 year | Value | 2025 | . |
| Position: single; < 40 year | Lower bound 95% confidence interval | 2025 | . |
| Position: single; < 40 year | Upper bound 95% confidence interval | 2025 | . |
| Position: single; 40 to 64 years | Value | 2025 | . |
| Position: single; 40 to 64 years | Lower bound 95% confidence interval | 2025 | . |
| Position: single; 40 to 64 years | Upper bound 95% confidence interval | 2025 | . |
| Position: single; >= 65 years | Value | 2025 | . |
| Position: single; >= 65 years | Lower bound 95% confidence interval | 2025 | . |
| Position: single; >= 65 years | Upper bound 95% confidence interval | 2025 | . |
| Position: child<18 yrs one-parent | Value | 2025 | . |
| Position: child<18 yrs one-parent | Lower bound 95% confidence interval | 2025 | . |
| Position: child<18 yrs one-parent | Upper bound 95% confidence interval | 2025 | . |
| Positon: child of age, one-parent househ | Value | 2025 | . |
| Positon: child of age, one-parent househ | Lower bound 95% confidence interval | 2025 | . |
| Positon: child of age, one-parent househ | Upper bound 95% confidence interval | 2025 | . |
| Position: child < 18 yrs, two-parents | Value | 2025 | . |
| Source: CBS. | |||
Table explanation
This table contains data on the perceived state of health and on contacts with providers of medical care of the Dutch population from 0 years on in private households. These data can be grouped by several personal characteristics. For several topics a different age demarcation applies. The age boundaries are listed at the relevant topics.
Data available from: 2014
Status of the data: final.
Changes by March 13, 2026
The 2025 figures have been added. The table has been expanded with information on diabetes (other than type 1 or type 2). As of 2025, the new topic "Neck disorder" will replace "disorder of the neck or shoulder", the new topic " Arthrosis, 12 plus " will replace " Arthrosis of Hip/knee 12 or older" and the new topic “Non-prescribed medicines, since 2025” will replace “Non-prescribed medicines (2014-2024)”. Besides that, the personal characteristic of poverty (classified as poor, near-poor and not poor or not near poor) has been added.
Within the characteristic 'position in household', the category 'other member of household' has been changed to 'member other household', because that is more correct and some minor textual changes are made in the explanations of the categories of positions in household.
When will new data be published?
Data on reporting year 2026 will be published in the second quarter of 2027.
Description topics
- Acute diseases
- Questions are asked on different acute diseases or complaints. With the answer ꞌyesꞌ or ꞌnoꞌ the respondent can indicate if he had the complaints during the last 2 months. The questions are asked to respondents of all ages. In 2019 and 2020, questions about acute illnesses or complaints were not included in the survey.
- Corona
- Percentage of persons who answered ꞌyesꞌ to the question: ꞌHave you / Has your child suffered from corona during the last 2 months?'
This question was asked in the years 2022 and 2023. In March 2023, the government advice to take a (self) test if there were symptoms that may indicate corona was discontinued. This may have made it more difficult for people to distinguish between corona on the one hand and colds/flu/strep throat/sinus infections on the other. From 2024, corona will no longer be asked separately, but this condition will be included in the question for other respiratory infections. The question is 'Have you or your child had a cold, flu, corona, throat infection or sinus infection in the past 2 months?'